Effectiveness of adalimumab in lichen sclerosus and lichen planopilaris in a psoriatic patient

Ital J Dermatol Venerol. 2023 Apr;158(2):154-155. doi: 10.23736/S2784-8671.23.07370-X. Epub 2023 Mar 21.

Authors

Dario Buononato¹, Giuseppe Argenziano², Graziella Babino², Anna Balato², Giovanni Cascone², Elisabetta Fulgione², Caterina M Giorgio²

Affiliations

¹ Unit of Dermatology, Department of Mentals and Physical Health and Preventive Medicine, Luigi Vanvitelli University of Campania, Naples, Italy - dario.buononato@gmail.com.
² Unit of Dermatology, Department of Mentals and Physical Health and Preventive Medicine, Luigi Vanvitelli University of Campania, Naples, Italy.

PMID: 36943387
DOI: 10.23736/S2784-8671.23.07370-X

No abstract available

MeSH terms

Adalimumab / therapeutic use
Humans
Lichen Planus* / drug therapy
Lichen Sclerosus et Atrophicus* / complications
Lichen Sclerosus et Atrophicus* / drug therapy

Substances

Adalimumab

Supplementary concepts

Lichen planus follicularis